G T Lainas
Overview
Explore the profile of G T Lainas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feferkorn I, Santos-Ribeiro S, Ubaldi F, Velasco J, Ata B, Blockeel C, et al.
J Assist Reprod Genet
. 2023 Dec;
41(2):519-520.
PMID: 38079078
No abstract available.
2.
Feferkorn I, Santos-Ribeiro S, Ubaldi F, Velasco J, Ata B, Blockeel C, et al.
J Assist Reprod Genet
. 2023 Sep;
40(11):2681-2695.
PMID: 37713144
Purpose: To provide agreed-upon guidelines on the management of a hyper-responsive patient undergoing ovarian stimulation (OS) METHODS: A literature search was performed regarding the management of hyper-response to OS for...
3.
Lainas G, Lainas T, Makris A, Xenariou M, Petsas G, Kolibianakis E
Hum Reprod
. 2023 Aug;
38(10):1927-1937.
PMID: 37632249
Study Question: Does follicular flushing increase the number of cumulus-oocyte complexes (COCs) retrieved compared to single aspiration? Summary Answer: Follicular flushing significantly increases the number of COCs retrieved compared to...
4.
Feferkorn I, Ata B, Esteves S, La Marca A, Paulson R, Blockeel C, et al.
J Assist Reprod Genet
. 2023 Mar;
40(5):1071-1081.
PMID: 36933094
Purpose: To provide an agreed upon definition of hyper-response for women undergoing ovarian stimulation (OS)? Methods: A literature search was performed regarding hyper-response to ovarian stimulation for assisted reproductive technology....
5.
Lainas G, Lainas T, Sfontouris I, Venetis C, Kyprianou M, Petsas G, et al.
Hum Reprod Open
. 2020 Jun;
2020(3):hoaa013.
PMID: 32529046
Study Question: Can the grade of ascites, haematocrit (Ht), white blood cell (WBC) count and maximal ovarian diameter (MOD) measured on Day 3 be used to construct a decision-making algorithm...
6.
Lainas G, Lainas T, Sfontouris I, Chatzimeletiou K, Venetis C, Bosdou J, et al.
Hum Reprod
. 2019 Aug;
34(9):1770-1777.
PMID: 31384921
Study Question: Are oocyte maturation rates different among 0.1, 0.2 and 0.4 mg triptorelin used for triggering final oocyte maturation in patients at high risk for ovarian hyperstimulation syndrome (OHSS)...
7.
Lainas G, Lainas T, Venetis C, Sfontouris I, Zorzovilis I, Alexopoulou E, et al.
Ultrasound Obstet Gynecol
. 2017 Nov;
51(1):126-133.
PMID: 29105961
Objective: To assess ultrasound and hematological changes during the early luteal phase following triggering of final oocyte maturation with human chorionic gonadotropin (hCG) in women at high risk for developing...
8.
Lainas G, Kolibianakis E, Sfontouris I, Zorzovilis I, Petsas G, Lainas T, et al.
BJOG
. 2014 Mar;
121(7):848-55.
PMID: 24621101
Objective: To investigate the kinetics of serum vascular endothelial growth factor (VEGF) following gonadotrophin-releasing hormone (GnRH) antagonist administration in the luteal phase in women with established severe early ovarian hyperstimulation...
9.
Lainas G, Kolibianakis E, Sfontouris I, Zorzovilis I, Petsas G, Lainas T, et al.
Hum Reprod
. 2013 Apr;
28(7):1929-42.
PMID: 23624582
Study Question: Do high-risk patients who develop severe early ovarian hyperstimulation syndrome (OHSS) and receive low-dose GnRH antagonist in the luteal phase have lower live birth rates compared with high-risk...
10.
Lainas T, Sfontouris I, Zorzovilis I, Petsas G, Lainas G, Alexopoulou E, et al.
Reprod Biomed Online
. 2009 Dec;
19(6):789-95.
PMID: 20031018
Ovarian hyperstimulation syndrome (OHSS) is a serious complication of ovarian stimulation protocols. Currently, no curative therapy exists and the main preventive option is cycle cancellation. Gonadotrophin-releasing hormone (GnRH) antagonist administration...